ARTHQ (Arch Therapeutics) Change In Inventory: $0.06 Mil (TTM As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics Change In Inventory?

Arch Therapeutics ARTHQ -99.00% 12 Change In Inventory is $0.06 Mil as of Jun. 2024. GuruFocus rates ARTHQ with a GF Score™ of 12/100.

Arch Therapeutics's change in inventory for the quarter that ended in Jun. 2024 was $0.01 Mil. It means Arch Therapeutics's inventory declined by $0.01 Mil from Mar. 2024 to Jun. 2024 .

Arch Therapeutics's change in inventory for the fiscal year that ended in Sep. 2023 was $0.05 Mil. It means Arch Therapeutics's inventory declined by $0.05 Mil from Sep. 2022 to Sep. 2023 .

Arch Therapeutics's Total Inventories for the quarter that ended in Jun. 2024 was $1.32 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Arch Therapeutics's Days Inventory for the quarter that ended in Jun. 2024 was 5,757.44.

Inventory Turnover measures how fast the company turns over its inventory within a year. Arch Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.02.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Arch Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 42.74.

Arch Therapeutics  (OTCPK:ARTHQ) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Arch Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1.325/0.021*365 / 4
=5,757.44

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Arch Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.021 / 1.325
=0.02

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Arch Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1.325 / 0.031
=42.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics Change In Inventory Related Terms

Arch Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Arch Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics Change In Inventory Chart

Arch Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.68 -0.31 -0.57 0.05

Arch Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.01 0.01
ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.06 Mil mean?
Arch Therapeutics (ARTHQ) has a Change In Inventory of $0.06 Mil as of Jun. 2024. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Arch Therapeutics and its competitors.
Is Arch Therapeutics' Change In Inventory too high?
Arch Therapeutics' current Change In Inventory is $0.06 Mil. Overall, Arch Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Arch Therapeutics' Change In Inventory compare to GRTSQ and MTEM?
Arch Therapeutics' Change In Inventory of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Arch Therapeutics and its competitors. Arch Therapeutics's current Change In Inventory is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Therapeutics stock overvalued right now?
Arch Therapeutics (ARTHQ) has a current Change In Inventory of $0.06 Mil. The current Change In Inventory is $0.06 Mil. Arch Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Arch Therapeutics (ARTHQ), the current Change In Inventory is $0.06 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price